Literature DB >> 9200412

Selective breeding for high serum IgA levels from noninbred ddY mice: isolation of a strain with an early onset of glomerular IgA deposition.

S Miyawaki1, E Muso, E Takeuchi, H Matsushima, Y Shibata, S Sasayama, H Yoshida.   

Abstract

An outbred mouse strain known as ddY has been reported to spontaneously develop, late in life, mesangioproliferative glomerulonephritis with a severe glomerular immunoglobulin A (IgA) deposition that mimics human IgA nephropathy. However, the incidence of the disease in this strain is not very high, probably due to its heterogeneous genetic background. Therefore, we attempted to isolate a strain with a high incidence and an early onset of the disease through selection for high serum IgA from the outbred ddY mice. The selection procedure was successful in increasing the serum IgA level of the selected line and proved effective both in increasing the incidence and in accelerating the onset of the disease. We propose to designate this line of mice 'HIGA', denoting a line with high serum IgA levels. More than half of the mice from the HIGA strain showed a moderate to severe glomerular IgA deposition as early as 25 weeks of age. The severe deposition observed was comparable to that occasionally seen in the original nonselected ddY strain after 40 weeks of age. Thus, we have succeeded in generating a mouse model of IgA nephropathy with a high incidence and an early onset of glomerular IgA deposition. Using light microscopy, progressive and marked mesangial matrix accumulation was shown to develop in HIGA mice. However, they showed only mild proteinuria (100-300 mg/dl) and did not show hematuria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200412     DOI: 10.1159/000190169

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.

Authors:  Toshikazu Nishie; Osamu Miyaishi; Haruhito Azuma; Akihiko Kameyama; Chie Naruse; Noriyoshi Hashimoto; Hitoshi Yokoyama; Hisashi Narimatsu; Takashi Wada; Masahide Asano
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

4.  The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Authors:  Angelique L Rops; Carl G Figdor; Alie van der Schaaf; Wim P Tamboer; Marinka A Bakker; Jo H Berden; Henry B P M Dijkman; Eric J Steenbergen; Johan van der Vlag; Annemiek B van Spriel
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 5.  Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

6.  Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients.

Authors:  C Geier; J Schröder; A Tamm; S Dietz; S Nuding; K Holder; Ö Khandanpour; K Werdan; H Ebelt
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-12-17       Impact factor: 0.840

7.  Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-03-02       Impact factor: 2.557

8.  Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-28       Impact factor: 2.557

Review 9.  Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.

Authors:  N Ohashi; M Urushihara; H Kobori
Journal:  Minerva Urol Nefrol       Date:  2009-03       Impact factor: 3.720

Review 10.  Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.

Authors:  Yelena Drexler; Judith Molina; Alla Mitrofanova; Alessia Fornoni; Sandra Merscher
Journal:  J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.